C9orf72 and amyotrophic lateral sclerosis: Our analyzed cohort included 22 patients, and the observed C9orf72 repeat expansion prevalence of 31.82% among ALS/FTD cases aligns with previous reports in other populations [36,37], as well as with review data indicating a frequency of approximately 30% [16].